Lastima, Narcesa N.

HRN: 28-64-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2026
METRONIDAZOLE 500MG (TAB)
03/06/2026
03/20/2026
PO
500 Mg
Bid
H Pylori
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: